who created retatrutide UK: New Triple-Agonist Weight Loss Injection Explained What Is Retatrutide? How Does

Finally, similar to GWAS studies, the authors used a stricter threshold for significance to account for the many statistical tests being done that could find things just by chance (to minimize the green jelly bean problem)

And I started thinking that there was a pattern there that needed to be investigated." Q: Your study found a 1.5% increase in hypotensive events in patients six months after starting GLP-1s

In terms of where the evidence sits right now, semaglutide has the strongest cardiac safety profile because it has the most data

Retatrutide remains investigational and is not commercially available, with access limited to clinical trial participation